Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 132

1.

Pretreatment Neutrophil-to-Lymphocyte Ratio Can Predict the Prognosis in Bladder Cancer Patients Who Receive Gemcitabine and Nedaplatin Therapy.

Ohtake S, Kawahara T, Kasahara R, Ito H, Osaka K, Hattori Y, Teranishi JI, Makiyama K, Mizuno N, Umemoto S, Miyoshi Y, Nakaigawa N, Miyamoto H, Yao M, Uemura H.

Biomed Res Int. 2016;2016:9846823. Epub 2016 Sep 8.

2.
3.

Neutrophil-to-lymphocyte ratio as a bladder cancer biomarker: Assessing prognostic and predictive value in SWOG 8710.

Ojerholm E, Smith A, Hwang WT, Baumann BC, Tucker KN, Lerner SP, Mamtani R, Boursi B, Christodouleas JP.

Cancer. 2017 Mar 1;123(5):794-801. doi: 10.1002/cncr.30422. Epub 2016 Oct 27.

4.

Pretreatment neutrophil-to-lymphocyte ratio is associated with advanced pathologic tumor stage and increased cancer-specific mortality among patients with urothelial carcinoma of the bladder undergoing radical cystectomy.

Viers BR, Boorjian SA, Frank I, Tarrell RF, Thapa P, Karnes RJ, Thompson RH, Tollefson MK.

Eur Urol. 2014 Dec;66(6):1157-64. doi: 10.1016/j.eururo.2014.02.042. Epub 2014 Feb 26.

PMID:
24630414
5.

Neutrophil to lymphocyte ratio, a biomarker in non-muscle invasive bladder cancer: a single-institutional longitudinal study.

Favilla V, Castelli T, Urzì D, Reale G, Privitera S, Salici A, Russo GI, Cimino S, Morgia G.

Int Braz J Urol. 2016 Jul-Aug;42(4):685-93. doi: 10.1590/S1677-5538.IBJU.2015.0243.

6.

Neutrophil-Lymphocyte Ratio Is a Prognostic Marker in Patients with Locally Advanced (Stage IIIA and IIIB) Non-Small Cell Lung Cancer Treated with Combined Modality Therapy.

Scilla KA, Bentzen SM, Lam VK, Mohindra P, Nichols EM, Vyfhuis MA, Bhooshan N, Feigenberg SJ, Edelman MJ, Feliciano JL.

Oncologist. 2017 Jun;22(6):737-742. doi: 10.1634/theoncologist.2016-0443. Epub 2017 May 22.

7.

Neutrophil-to-lymphocyte ratio is a prognostic marker in bladder cancer patients after radical cystectomy.

Kawahara T, Furuya K, Nakamura M, Sakamaki K, Osaka K, Ito H, Ito Y, Izumi K, Ohtake S, Miyoshi Y, Makiyama K, Nakaigawa N, Yamanaka T, Miyamoto H, Yao M, Uemura H.

BMC Cancer. 2016 Mar 5;16:185. doi: 10.1186/s12885-016-2219-z.

8.

Low Pretreatment Neutrophil-to-Lymphocyte Ratio Predicts for Good Outcomes in Patients Receiving Neoadjuvant Chemotherapy Before Radical Cystectomy for Muscle Invasive Bladder Cancer.

Buisan O, Orsola A, Areal J, Font A, Oliveira M, Martinez R, Ibarz L.

Clin Genitourin Cancer. 2017 Feb;15(1):145-151.e2. doi: 10.1016/j.clgc.2016.05.004. Epub 2016 Jun 1.

PMID:
27364982
9.

Can the Preoperative Neutrophil-to-Lymphocyte Ratio Significantly Predict the Conditional Survival Probability in Muscle-invasive Bladder Cancer Patients Undergoing Radical Cystectomy?

Kang M, Balpukov UJ, Jeong CW, Kwak C, Kim HH, Ku JH.

Clin Genitourin Cancer. 2017 Jun;15(3):e411-e420. doi: 10.1016/j.clgc.2016.10.015. Epub 2017 Jan 9.

PMID:
28162942
10.

Prognostic value of neutrophil-to-lymphocyte ratio in advanced oesophago-gastric cancer: exploratory analysis of the REAL-2 trial.

Grenader T, Waddell T, Peckitt C, Oates J, Starling N, Cunningham D, Bridgewater J.

Ann Oncol. 2016 Apr;27(4):687-92. doi: 10.1093/annonc/mdw012. Epub 2016 Jan 19.

PMID:
26787231
11.

A Low Psoas Muscle Index before Treatment Can Predict a Poorer Prognosis in Advanced Bladder Cancer Patients Who Receive Gemcitabine and Nedaplatin Therapy.

Kasahara R, Kawahara T, Ohtake S, Saitoh Y, Tsutsumi S, Teranishi JI, Miyoshi Y, Nakaigawa N, Yao M, Kobayashi K, Uemura H.

Biomed Res Int. 2017;2017:7981549. doi: 10.1155/2017/7981549. Epub 2017 Apr 13.

12.

Preoperative lymphocyte-monocyte and platelet-lymphocyte ratios as predictors of overall survival in patients with bladder cancer undergoing radical cystectomy.

Zhang GM, Zhu Y, Luo L, Wan FN, Zhu YP, Sun LJ, Ye DW.

Tumour Biol. 2015 Nov;36(11):8537-43. doi: 10.1007/s13277-015-3613-x. Epub 2015 Jun 2.

PMID:
26032095
13.

Blood neutrophil-lymphocyte ratio predicts survival for stages III-IV gastric cancer treated with neoadjuvant chemotherapy.

Jin H, Zhang G, Liu X, Liu X, Chen C, Yu H, Huang X, Zhang Q, Yu J.

World J Surg Oncol. 2013 May 24;11:112. doi: 10.1186/1477-7819-11-112.

14.

Prognostic significance of neutrophil lymphocyte ratio and platelet lymphocyte ratio in advanced gastric cancer patients treated with FOLFOX chemotherapy.

Lee S, Oh SY, Kim SH, Lee JH, Kim MC, Kim KH, Kim HJ.

BMC Cancer. 2013 Jul 22;13:350. doi: 10.1186/1471-2407-13-350.

15.

Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Primary Non-muscle-invasive Bladder Cancer.

D'Andrea D, Moschini M, Gust K, Abufaraj M, Özsoy M, Mathieu R, Soria F, Briganti A, Rouprêt M, Karakiewicz PI, Shariat SF.

Clin Genitourin Cancer. 2017 Oct;15(5):e755-e764. doi: 10.1016/j.clgc.2017.03.007. Epub 2017 Mar 27.

PMID:
28420564
16.

Prognostic value of pretreatment inflammatory biomarkers in advanced lung adenocarcinoma patients receiving first-line pemetrexed/platinum doublet.

Xiong Y, Zhao N, Zheng Y, Wang J, Wei F, Ren X.

Tumour Biol. 2017 Jun;39(6):1010428317701639. doi: 10.1177/1010428317701639.

PMID:
28618954
17.

Neutrophil-to-lymphocyte ratio as a detection marker of tumor recurrence in patients with muscle-invasive bladder cancer after radical cystectomy.

Morizawa Y, Miyake M, Shimada K, Hori S, Tatsumi Y, Nakai Y, Anai S, Tanaka N, Konishi N, Fujimoto K.

Urol Oncol. 2016 Jun;34(6):257.e11-7. doi: 10.1016/j.urolonc.2016.02.012. Epub 2016 Mar 30.

PMID:
27038696
18.

The Preoperative Neutrophil-to-lymphocyte Ratio is a Novel Biomarker for Predicting Worse Clinical Outcomes in Non-muscle Invasive Bladder Cancer Patients with a Previous History of Smoking.

Ogihara K, Kikuchi E, Yuge K, Yanai Y, Matsumoto K, Miyajima A, Asakura H, Oya M.

Ann Surg Oncol. 2016 Dec;23(Suppl 5):1039-1047. Epub 2016 Sep 22.

PMID:
27660257
19.

Pre-treatment neutrophil-to-lymphocyte ratio as predictor of adverse outcomes in patients undergoing radical cystectomy for urothelial carcinoma of the bladder.

Hermanns T, Bhindi B, Wei Y, Yu J, Noon AP, Richard PO, Bhatt JR, Almatar A, Jewett MA, Fleshner NE, Zlotta AR, Templeton AJ, Kulkarni GS.

Br J Cancer. 2014 Jul 29;111(3):444-51. doi: 10.1038/bjc.2014.305. Epub 2014 Jun 10.

20.

Can neutrophil to lymphocyte ratio predict lamina propria invasion in patients with non muscle invasive bladder cancer?

Cimen HI, Halis F, Saglam HS, Gokce A.

Int Braz J Urol. 2017 Jan-Feb;43(1):67-72. doi: 10.1590/S1677-5538.IBJU.2016.0158.

Supplemental Content

Support Center